One of the major challenges in preventing glaucoma progression is patient compliance with medication regimens. Since conventional ophthalmic dosage forms have numerous limitations, researchers have been intensively working on developing polymers-based delivery systems for glaucoma drugs. Specifically, research and development efforts have increased using polysaccharide polymers such as sodium alginate, cellulose, β-cyclodextrin, hyaluronic acid, chitosan, pectin, gellan gum, galactomannans for sustained release to the eye to overcome treatment challenges, showing promise in improving drug release and delivery, patient experience, and treatment compliance. In the recent past, multiple research groups have successfully designed sustained drug delivery systems, promoting the efficacy as well as the feasibility of glaucoma drugs with single/combinations of polysaccharides to eliminate the drawbacks associated with the glaucoma treatment. Naturally available polysaccharides, when used as drug vehicles can increase the retention time of eye drops on the ocular surface, leading to improved drug absorption and bioavailability. Additionally, some polysaccharides can form gels or matrices that can release drugs slowly over time, providing sustained drug delivery and reducing the need for frequent dosing. Thus, this review aims to provide an overview of the pre-clinical and clinical studies of polysaccharide polymers applied for glaucoma treatment along with their therapeutic outcomes.
PatelKDSilvaLBParkY, et al.Recent advances in drug delivery systems for glaucoma treatment. Mater Today Nano2022; 18: 100178.
2.
WuYSzymanskaMHuY, et al.Measures of disease activity in glaucoma. Biosens Bioelectron2022; 196: 113700.
3.
W. H. Organization, others. World report on vision. Geneva: World Health Organization; 2019, (2020).
4.
MuramatsuCHayashiYSawadaA, et al.Detection of retinal nerve fiber layer defects on retinal fundus images for early diagnosis of glaucoma. J Biomed Opt2010; 15: 16021.
5.
ChandramohanHWan Abdul HalimWHAziziHA, et al.Quality of Life and Severity of Glaucoma: A Study Using Glaucol-36 Questionnaire at Universiti Kebangsaan Malaysia Medical Centre (UKMMC). Int Med J2017; 24: 61–64.
6.
Lazcano-GomezGdelos Angeles Ramos-CadenaMTorres-TamayoM, et al.J.Jimenez-Román, Cost of glaucoma treatment in a developing country over a 5-year period. Medicine (Baltimore)2016; 95: 1–5.
7.
VarmaRLeePPGoldbergI,et al.An assessment of the health and economic burdens of glaucoma. Am J Ophthalmol2011; 152: 515–522.
8.
Al-ShohaniADH. Hydrogel Formulations for Ophthalmic Delivery, UCL. London: University College, 2017.
9.
UrttiA. Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv Drug Deliv Rev2006; 58: 1131–1135.
10.
SponselWEParisGTrigoY,et al.Comparative effects of latanoprost (Xalatan) and unoprostone (rescula) in patients with open-angle glaucoma and suspected glaucoma. Am J Ophthalmol2002; 134: 552–559.
11.
PriluckAZDietzeJ. Ophthalmologist and optometrist glaucoma prescribing patterns based on 2015 medicare part D data. Ophthalmol Glaucoma2019; 2: 63–66.
12.
ZiadiAOzmaieSAsghariA,et al.Effect of topically applied 0.5\% apraclonidine versus 0.5\% timolol maleate on intraocular pressure of healthy horses. J Equine Vet Sci2022; 111: 103886.
13.
OkumuraNOkazakiYInoueR, et al.Rho-associated kinase inhibitor eye drop (Ripasudil) transiently alters the morphology of corneal endothelial cells. Investig Ophthalmol Vis Sci2015; 56: 7560–7567.
14.
HanSBLiuY-CMohamed-NoriegaK,et al.Application of novel drugs for corneal cell regeneration. J Ophthalmol2018; 2018: 1–9. https://doi.org/10.1155/2018/1215868
15.
NoeckerR. Effects of common ophthalmic preservatives on ocular health. Adv Ther2001; 18: 205–215.
16.
WiseJB. Ten year results of laser trabeculoplasty: does the laser avoid glaucoma surgery or merely defer it?Eye1987; 1: 45–50.
17.
AyyalaRSMichelini-NorrisBFloresA, et al.Comparison of different biomaterials for glaucoma drainage devices: part 2. Arch Ophthalmol2000; 118: 1081–1084.
ZhaoXSiJHuangD, et al.Application of star poly (ethylene glycol) derivatives in drug delivery and controlled release. J Control Release2020; 323: 565–577.
20.
NiZYuHWangL, et al.Recent research progress on polyphosphazene-based drug delivery systems. J Mater Chem B2020; 8: 1555–1575.
21.
BesfordQACavalieriFCarusoF. Glycogen as a building block for advanced biological materials. Adv Mater2020; 32: 1904625.
22.
AllynMMLuoRHHellwarthEB,et al.Considerations for polymers used in ocular drug delivery. Front Med ; n.d; 8: 2963.
23.
ElHoffyNMAzimEAAHathoutRM, et al.Glaucoma: management and future perspectives for nanotechnology-based treatment modalities. Eur J Pharm Sci2021; 158: 105648.
24.
RabeaEIBadawyME-TVStevensC, et al.Chitosan as antimicrobial agent: applications and mode of action. Biomacromolecules2003; 4: 1457–1465.
25.
LiuJZhanXWanJ, et al.Review for carrageenan-based pharmaceutical biomaterials: favourable physical features versus adverse biological effects. Carbohydr Polym2015; 121: 27–36.
26.
ZiaKMTabasumSKhanMF, et al.Recent trends on gellan gum blends with natural and synthetic polymers: a review. Int J Biol Macromol2018; 109: 1068–1087.
27.
FreitasCMPCoimbraJSRSouzaVGL,et al.Structure and applications of pectin in food, biomedical, and pharmaceutical industry: a review. Coatings2021; 11: 922.
28.
ZarrintajPManouchehriSAhmadiZ, et al.Agarose-based biomaterials for tissue engineering. Carbohydr Polym2018; 187: 66–84.
SunBZhangMShenJ, et al.Applications of cellulose-based materials in sustained drug delivery systems. Curr Med Chem2019; 26: 2485–2501.
31.
JiangTDuanQZhuJ, et al.Starch-based biodegradable materials: challenges and opportunities. Adv Ind Eng Polym Res2020; 3: 8–18.
32.
KianersiSSoloukASaber-SamandariS, et al.Alginate nanoparticles as ocular drug delivery carriers. J Drug Deliv Sci Technol2021; 66: 102889. https://doi.org/10.1016/j.jddst.2021.102889
33.
GuptaHAqilMKharRK, et al.An alternative in situ gel-formulation of levofloxacin eye drops for prolong ocular retention. J Pharm & Bioallied Sci2015; 7: 9.
34.
NunesCSilvaLFernandesAP, et al.Occurrence of cellobiose residues directly linked to galacturonic acid in pectic polysaccharides. Carbohydr Polym2012; 87: 620–626.
35.
Lara-EspinozaCCarvajal-MillánEBalandrán-QuintanaR, et al.Pectin and pectin-based composite materials: beyond food texture. Molecules2018; 23: 942.
GrassiriBZambitoYBernkop-SchnürchA. Strategies to prolong the residence time of drug delivery systems on ocular surface. Adv Colloid Interface Sci2021; 288: 102342.
38.
ChengK-JHsiehC-MNepaliK,et al.Ocular disease therapeutics: design and delivery of drugs for diseases of the eye. J Med Chem2020; 63: 10533–10593.
39.
KumaraBNShambhuRPrasadKS. Why chitosan could be apt candidate for glaucoma drug delivery-an overview. Int J Biol Macromol2021; 176: 47–65. https://doi.org/10.1016/j.ijbiomac.2021.02.057
40.
HonDN-S. Cellulose and its derivatives: structures, reactions, and medical uses, in: Polysaccharides Med. Appl., Routledge, 2017: pp. 87–105.
41.
GuptaBMishraVGharatS, et al.Cellulosic polymers for enhancing drug bioavailability in ocular drug delivery systems. Pharmaceuticals2021; 14: 1201. https://doi.org/10.3390/ph14111201
42.
VendrusculoCTPereiraJLScampariniARP. Gellan gum: production and properties. In: NishinariKDoiE (eds) Food hydrocoll. Struct. Prop. Funct.Boston, MA: Springer US, 1993, pp.91–95. https://doi.org/10.1007/978-1-4615-2486-1_9
43.
BacelarAHSilva-CorreiaJOliveiraJM,et al.Recent progress in gellan gum hydrogels provided by functionalization strategies. J Mater Chem B2016; 4: 6164–6174.
PrajapatiVDMaheriyaPMRoySD. Locust bean gum-derived hydrogels, in: Plant Algal Hydrogels Drug Deliv. Regen. Med., Elsevier, 2021: pp. 217–260.
46.
YadavHMaitiS. Research progress in galactomannan-based nanomaterials: synthesis and application. Int J Biol Macromol2020; 163: 2113–2126. https://doi.org/10.1016/j.ijbiomac.2020.09.062
47.
MatencioACalderaFCeconeC, et al.Cyclic oligosaccharides as active drugs, an updated review. Pharmaceuticals2020; 13: 281.
48.
SandilyaAANatarajanUPriyaMH. Molecular view into the cyclodextrin cavity: structure and hydration. ACS Omega2020; 5: 25655–25667.
49.
AsimMHIjazMMahmoodA, et al.Thiolated cyclodextrins: mucoadhesive and permeation enhancing excipients for ocular drug delivery. Int J Pharm2021; 599: 120451. https://doi.org/10.1016/j.ijpharm.2021.120451
50.
RussoESelminFBaldassariS, et al.A focus on mucoadhesive polymers and their application in buccal dosage forms. J Drug Deliv Sci Technol2016; 32: 113–125.
51.
JawadiZYangCHaidarZS, et al.Bio-Inspired Muco-adhesive polymers for drug delivery applications. Polymers (Basel)2022; 14: 5459.
ChawananorasestKSaengtongdeePKaemchantuekP. Extraction and characterization of tamarind (Tamarind indica L.) seed polysaccharides (TSP) from three difference sources. Molecules2016; 21: 775.
54.
deCastroMAPrataWMCunhaAS. Tamarind seed polysaccharide (TSP) uses in ophthalmic drug delivery. Rev Ciências Farm Básica e Apl2022; 43: 1–10. https://doi.org/10.4322/2179-443X.0757
55.
JonasJB. Role of cerebrospinal fluid pressure in the pathogenesis of glaucoma. Acta Ophthalmol2011; 89: 505–514.
56.
Rocha-SousaARodrigues-AraújoJGouveiaP, et al.New therapeutic targets for intraocular pressure lowering. Int Sch Res Not2013; 2013: 1–4.
57.
TseAPShahMJamalN,et al.Glaucoma treatment adherence at a United Kingdom general practice. Eye2016; 30: 1118–1122. https://doi.org/10.1038/eye.2016.103
MittalNKaurG. Leucaena leucocephala (Lam.) galactomannan nanoparticles: optimization and characterization for ocular delivery in glaucoma treatment. Int J Biol Macromol2019; 139: 1252–1262.
60.
JainNVermaAJainN. Formulation and investigation of pilocarpine hydrochloride niosomal gels for the treatment of glaucoma: intraocular pressure measurement in white albino rabbits. Drug Deliv2020; 27: 888–899.
61.
DurakSEsmaeili RadMAlp YetisginA, et al.Niosomal drug delivery systems for ocular disease—recent advances and future prospects. Nanomaterials2020; 10: 1191.
62.
MujoriyaRZDhamandebKBodlaRB. Niosomal drug delivery system—a review. Int j Appl Pharm2011; 3: 7–10.
63.
AllamAElsabahyMElBadryM,et al.Betaxolol-loaded niosomes integrated within pH-sensitive in situ forming gel for management of glaucoma. Int J Pharm2021; 598: 120380.
64.
RamadanAAEladawySAEl-EninASMA,et al.Development and investigation of timolol maleate niosomal formulations for the treatment of glaucoma. J Pharm Investig2020; 50: 59–70.
65.
MaulviFASoniTGShahDO. Extended release of timolol from ethyl cellulose microparticles laden hydrogel contact lenses. Open Pharm Sci J2015; 2: 1–12.
66.
DesaiARMaulviFAPandyaMM, et al.Co-delivery of timolol and hyaluronic acid from semi-circular ring-implanted contact lenses for the treatment of glaucoma: in vitro and in vivo evaluation. Biomater Sci2018; 6: 1580–1591.
67.
El-FekyYAFaresARZayedG, et al.Repurposing of nifedipine loaded in situ ophthalmic gel as a novel approach for glaucoma treatment. Biomed & Pharmacother2021; 142: 112008.
68.
RussoGGrumettoLBaertM,et al.Comprehensive two-dimensional liquid chromatography as a biomimetic screening platform for pharmacokinetic profiling of compound libraries in early drug development. Anal Chim Acta2021; 1142: 157–168.
69.
KulkarniGTSethiNAwasthiR, et al.Development of ocular delivery system for glaucoma therapy using natural hydrogel as film forming agent and release modifier. Polym Med2016; 46: 25–33.
70.
SunJZhouZ. A novel ocular delivery of brinzolamide based on gellan gum: in vitro and in vivo evaluation. Drug Des Devel Ther2018; 12: 383.
71.
WangFBaoXFangA, et al.Nanoliposome-encapsulated brinzolamide-hydropropyl-$β$-cyclodextrin inclusion complex: a potential therapeutic ocular drug-delivery system. Front Pharmacol2018; 9: 91.
72.
HuXTanHHaoL. Functional hydrogel contact lens for drug delivery in the application of oculopathy therapy. J Mech Behav Biomed Mater2016; 64: 43–52.
73.
DeSouzaJFMaiaKNPatr\’\icioPSDO, et al.Ocular inserts based on chitosan and brimonidine tartrate: development, characterization and biocompatibility. J Drug Deliv Sci Technol2016; 32: 21–30.
74.
LiJJinXZhangL, et al.Comparison of different chitosan lipid nanoparticles for improved ophthalmic tetrandrine delivery: formulation, characterization, pharmacokinetic and molecular dynamics simulation. J Pharm Sci2020; 109: 3625–3635.
75.
BarwalIKumarRDadaT,et al.Effect of ultra-small chitosan nanoparticles doped with brimonidine on the ultra-structure of the trabecular meshwork of glaucoma patients. Microsc Microanal2019; 25: 1352–1366.
76.
ChoISParkCGHuhBK, et al.Thermosensitive hexanoyl glycol chitosan-based ocular delivery system for glaucoma therapy. Acta Biomater2016; 39: 124–132.
77.
PakzadYFathiMOmidiY, et al.Synthesis and characterization of timolol maleate-loaded quaternized chitosan-based thermosensitive hydrogel: a transparent topical ocular delivery system for the treatment of glaucoma. Int J Biol Macromol2020; 159: 117–128.
78.
DubeyVMohanPDangiJS,et al.Brinzolamide loaded chitosan-pectin mucoadhesive nanocapsules for management of glaucoma: formulation, characterization and pharmacodynamic study. Int J Biol Macromol2020; 152: 1224–1232.
79.
MittalNKaurG. In situ gelling ophthalmic drug delivery system: Formulation and evaluation. J Appl Polym Sci2014; 131: 1–9.
80.
WangLJiangY-YLinN. Promise of latanoprost and timolol loaded combinatorial nanosheet for therapeutic applications in glaucoma. J King Saud Univ2020; 32: 1042–1047.
81.
IlkaRMohseniMKianiradM, et al.Nanogel-based natural polymers as smart carriers for the controlled delivery of timolol maleate through the cornea for glaucoma. Int J Biol Macromol2018; 109: 955–962.
82.
AfsharipourSPardakhtyAKazemipourM, et al.Formulation and physicochemical characterization of magnetic nanoparticles containing brimonidine for ophthalmic drug delivery. Int Pharm Actan.d.; 1: 103.
83.
WangFSongYHuangJ, et al.Lollipop-Inspired multilayered drug delivery hydrogel for dual effective, long-term, and NIR-defined glaucoma treatment. Macromol Biosci2021; 21: 2100202.
84.
KatariaPKataraRSahooPK,et al.Dorzolamide in situ gel forming system: characterization and evaluation for glaucoma treatment. Madridge J Pharm Res2017; 1: 13–21.
85.
VNairRShefrinSSureshA, et al.Sustained release timolol maleate loaded ocusert based on biopolymer composite. Int J Biol Macromol2018; 110: 308–317.
86.
AbdouEMKandilSM. Formulation and evaluation of dorzolamide and timolol ocuserts. Int J Pharm Sci Res2017; 8: 915.
87.
CallesJAMoraMJOnnaintyR, et al.Cross-linked hyaluronan films loaded with Acetazolamide–cyclodextrin–triethanolamine complexes for glaucoma treatment. Ther Deliv2018; 9: 205–220.
ShelkeNBJamesRLaurencinCT,et al.Polysaccharide biomaterials for drug delivery and regenerative engineering. Polym Adv Technol2014; 25: 448–460.
90.
MoCXiangLChenY. Advances in injectable and self-healing polysaccharide hydrogel based on the schiff base reaction. Macromol Rapid Commun2021; 42: 2100025.
91.
DubashynskayaNPoshinaDRaikS, et al.Polysaccharides in ocular drug delivery. Pharmaceutics2019; 12: 22.
92.
ZhangWZhaoYXuL, et al.Superfine grinding induced amorphization and increased solubility of $α$-chitin. Carbohydr Polym2020; 237: 116145.
93.
WangHZhaoXHuangY, et al.Rapid quality control of medicine and food dual purpose plant polysaccharides by matrix assisted laser desorption/ionization mass spectrometry. Analyst2020; 145: 2168–2175.
94.
YangJ-SXieY-JHeW. Research progress on chemical modification of alginate: a review. Carbohydr Polym2011; 84: 33–39.
95.
ChenJLiuWLiuC-M, et al.Pectin modifications: a review. Crit Rev Food Sci Nutr2015; 55: 1684–1698.
96.
KumarMNVRMuzzarelliRMuzzarelliC, et al.Chitosan chemistry and pharmaceutical perspectives. Chem Rev2004; 104: 6017–6084.
97.
KamideKSaitoM. Cellulose and cellulose derivatives: recent advances in physical chemistry. Biopolymers2005; 83: 1–56.
PrajapatiVDJaniGKMoradiyaNG, et al.Galactomannan: a versatile biodegradable seed polysaccharide. Int J Biol Macromol2013; 60: 83–92.
100.
KhanRMahendhiranBAroulmojiV. Chemistry of hyaluronic acid and its significance in drug delivery strategies: a review. Int J Pharm Sci Res2013; 4: 3699–3710.
101.
NayakAKPalD. Functionalization of tamarind gum for drug delivery. Funct Biopolym2018; 2: 25–56.
102.
WangSXuFHeJ, et al.Microspheres scar formation glaucoma filtration surgery area therapeutic effect—based on rapamycin-chitosan-calcium alginate sustained-release. Mater Express2020; 10: 848–855.
